Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
Author(s) -
Sagnik Bhattacharyya,
Robin Wilson,
Elizabeth AppiahKusi,
Aisling O’Neill,
Michael J. Brammer,
Jesús Pérez,
Robin M. Murray,
Paul Allen,
Matthijs G. Bossong,
Philip McGuire
Publication year - 2018
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2018.2309
Subject(s) - psychosis , placebo , antipsychotic , psychology , medicine , randomized controlled trial , psychiatry , schizophrenia (object oriented programming) , pathology , alternative medicine
Cannabidiol (CBD) has antipsychotic effects in humans, but how these are mediated in the brain remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom